Amy Hazel
Nurse Practitioner · Canton, OHNPI 1568468965
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Fresenius USA Marketing, Inc. at 51.3% of the total. Among nurse practitioner clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 485 payments — averaging $129.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Fresenius USA Marketing, Inc.$32K
- Bayer$8K
- Akebia Therapeutics Inc$7K
- Novartis$5K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$4K
- AstraZeneca$1K
- plus $6K from 32 others
What the payments were for
- Consulting fees$6,73811%
- Speaking & faculty fees$35,46857%
- Travel & lodging$8,26713%
- Food & beverage$11,44218%
- Education$8131%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$62,728 in reported general payments places this provider in the 95th percentile of 4,700 nurse practitioner providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 52 | $50,331 |
| VelphoroSucroferric Oxyhydroxide | 12 | $37,680 |
| AuryxiaFerric Citrate | 24 | $29,116 |
| ProsolParenteral Amino Acid 20% No.1 | 111 | $18,635 |
| Sevelamer Carbonate | 103 | $13,759 |
| LokelmaSodium Zirconium Cyclosilicate | 16 | $12,479 |
| KerendiaFinerenone | 17 | $10,636 |
| Calcitriol | 179 | $3,252 |
| Bumetanide | 60 | $2,332 |
| Hydralazine Hcl | 132 | $1,781 |
| Clonidine | 12 | $1,465 |
| Calcium Acetate | 23 | $1,398 |
| Doxazosin Mesylate | 87 | $1,394 |
| Matzim LaDiltiazem Hcl | 12 | $1,213 |
| Nifedipine ErNifedipine | 66 | $1,210 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Lokelma | $1,115 | $62,81068 claims |
| Fresenius USA Marketing, Inc.Velphoro | $32,203 | $37,68012 claims |
| Akebia Therapeutics IncAuryxia | $7,178 | $29,11624 claims |
| BayerKerendia | $7,556 | $10,63617 claims |
| ANI Pharmaceuticals, Inc.Valsartan | $91 | $80228 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,700 nurse practitioner providers in Ohio.
Other nurse practitioner in Canton
- Kristin BarnesCanton$9K
- Margaret BobonichCleveland$235K
- Mary GallagherWestlake$229K
- Sonia HissettCincinnati$179K
- Ashley TaylorNew Albany$107K
- Beth FaimanCleveland$101K
- Katherine AlexanderColumbus$99K
- Tiffany JonesCincinnati$99K
- Kate NewmanWestlake$78K
- Daniella GerySouth Euclid$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.